A CLINICAL PHARMACIST APPROACH ON CORONARY ARTERY DISEASE THROUGH CARDIAC REHABILITATION PROGRAM AT TERTIARY CARE HOSPITAL
Main Article Content
Keywords
Clinical Pharmacist; Coronary Artery Diseases; Cardiac Rehabilitation; Tertiary Care Hospital Approach
Abstract
Globally, coronary artery disorders (CAD) continue to be the primary cause of morbidity and mortality. Therefore, successful care of CAD requires a comprehensive and multidisciplinary approach. The objective of the study is to evaluate the role of clinical pharmacists in tertiary care institutions' cardiac rehabilitation programs and their impact on the management of coronary artery disorders (CAD). This prospective study enrolled hospital patients consulting physicians for coronary artery disease over six months. Statistical analyses were performed using Statistical Package for Social Science (SPSS) version 16 to evaluate demographic characteristics, clinical presentations, medication prescriptions, and physiological parameters. The investigation of 70 CAD patients revealed a male predominance and varied clinical manifestations, with acute coronary syndrome being most prevalent. Pharmacotherapy focused on antiplatelet, antihypertensive, anti-hyperlipidaemic, and anti-anginal agents, addressing drug therapy problems such as interactions and duplications. Physiological parameters improved post-rehabilitation, including ejection fraction, BMI, blood pressure, heart rate, FBS, Serum Creatinine, serum potassium, and total cholesterol. Patient knowledge and adherence significantly increased through Dose, Frequency, Indication, Method of administration and Medication Adherence Rating Scale assessments. The integration of clinical pharmacists in tertiary care institutions' cardiac rehabilitation programs is essential for the comprehensive management of CAD. Their involvement improves medication adherence, clinical outcomes, and overall quality of life for patients with CAD. Incorporating clinical pharmacists into multidisciplinary teams enhances the effectiveness of cardiac rehabilitation programs and underscores the importance of a holistic approach to CAD management.
Downloads
References
1. Al-Hashemi F, Heba D, Hamad A, et al. Impact of a pharmacist-led cardiovascular risk reduction clinic on lipid management in a secondary care setting. Int J Clin Pharm. 2019;41(3):684-690. 2. Bakar ZA, Sabe MA, Zin CS, Hassan Y. Role of pharmacist in cardiovascular disease management: the Malaysian experience. Integr Pharm Res Pract. 2019;8:119-126. 3. Brown TJ, Todd A, O'Malley C, et al. Community pharmacy interventions for public health priorities: a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions. Public Health Res. 2016;4(2):1-199. 4. Chisholm-Burns MA, Spivey CA, Gatwood J, et al. Evaluating the effects of a pharmacist-led comprehensive medication management and longitudinal medication therapy management program in primary care on diabetes-related clinical outcomes. J Manag Care Spec Pharm. 2018;24(3):275-283. 5. Costa FA, Scullin C, Al-Taani G, et al. Provision of pharmaceutical care by community pharmacists across Europe: is it developing and spreading. J Eval Clin Pract. 2017;23(6):1336-1347. 6. El-Rabbat NB, Hamad FBS, Mostafa A, et al. Role of clinical pharmacist in pharmacovigilance and adverse drug reaction reporting: A cross-sectional study from secondary and tertiary care hospitals in Saudi Arabia. Saudi Pharm J. 2018;26(6):854-860. 7. Ensing HT, Stuijt CCM, van den Bemt BJF, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614-636. 8. Fornos-Pérez JA, Andrés-Rodríguez NF, Andrés-Iglesias JC, et al. Effectiveness of a pharmacist intervention in patients with depression: a randomized, controlled trial. J Clin Pharm Ther. 2019;44(6):904-911. 9. Jaber D, Nasser R, Tayyem R, et al. Pharmaceutical care services and the management of coronary heart disease in Jordan: views of patients. Int J Clin Pharm. 2017;39(3):610-616. 10. Jodar-Sanchez F, Malet-Larrea A, Martin JJ, et al. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program. Pharmacoeconomics. 2015;33(6):599-610. 11. Kälvemark Sporrong S, Ingman P, Mäkeläinen L, et al. Patient empowerment and its relation to patient-centered care and outcomes in diabetes. J Clin Pharm Ther. 2020;45(2):246-253. 12. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2016;296(21):2563-2571. 13. Lowry F. 'Virtual' pharmacist intervention boosts adherence in CVD. Medscape Medical News. 2016. Accessed November 15, 2020. https://www.medscape.com/viewarticle/872747 14. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168(21):2355-2361. 15. Palagyi A, Keay L, Harper J, et al. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr. 2016;16:15. 16. Rotta I, Salgado TM, Silva ML, et al. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000-2010). Int J Clin Pharm. 2015;37(5):687-697. 17. Schulz M, Verheyen F, Mühlig S, et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol. 2001;41(6):668-676. 18. Van der Laan DM, Elders PJ, Boons CC, et al. The (cost-)effectiveness of a lifestyle physical activity intervention in addition to a work style intervention on the recovery from neck and upper limb symptoms in computer workers. BMC Musculoskelet Disord. 2017;18(1):328. 19. Vassilev I, Rowsell A, Pope C, et al. Assessing the implementability of telehealth interventions for self-management support: a realist review. Implement Sci. 2015;10:59. doi:10.1186/s13012-015-0254-0 20. Weber CA, Ernst ME, Sezate GS, et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170(18):1634-1639.
Article Sidebar
Article Details
Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.